-
Primerjava učinkovitosti cefpiramida (tamicin) in cefotaksima pri zdravljenju hudih bolnišničnih in izvenbolnišničnih okužb = Treatment of serious hospital and community acquired infection: cefpiramide (tamicin) versus cefotaximeMuzlovič, Igor ...Backgraund. The activity of cefpiramide is usually compared to activity of cefoperazone against P. aeruginosa. It has about the same activity as cefotaxim and ceftriaxone against gram negative ... bacteria. In prospective randomised clinical trial the activity of cefpiramide (Tamicin/R) was comparedto that of cefotoxim in patients who suffered from serious nosocomial and community acquired infections. Methods. Thirty-one patients with pneumonia, sepsis or urinary tract infection were randomly assigned to one of the two groups. Patients in the first group received intravenous cefpiramide and patients in the second group received intravenous cefotaxim. There was no difference between groups according to demographic characteristics. Results. Cefpiramide was clinically successful in 85.7% and 78.5% of cases showed eradication of causative pathogen. Cefotaxim was clinically successful in 76.4% and eradication rate was 85.7%. The most frequent isolated bacteria in both groups were E. coli, K. pneumoniae and P. aeruginosa. E. cloacae was morefrequently in cefpiramide group and S. aureus in cefotaxim group. There were no differences in the both groups according to colonization, superinfection or side effects. Conclusions. Cefpiramide and cefotaxim were equally effective and safe in patients with serious hospital and community acquired infections. Treatment with these drugs is recommended in infections that are not multiresistant in origin.Vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Let. 66, št. 3, 1997, str. 123-126)Vrsta gradiva - članek, sestavni delLeto - 1997Jezik - slovenskiCOBISS.SI-ID - 7249625
Avtor
Muzlovič, Igor |
Jereb, Matjaž, 1961- |
Beović, Bojana |
Tomažič, Janez, 1954- |
Pikelj, Franjo
Teme
Cross infection |
Drug therapy |
Community-acquired infections |
Drug therapy |
Pneumonia |
Drug therapy |
Etiology |
Sepsis |
Drug therapy |
Etiology |
Pyelonephritis |
Drug therapy |
Etiology |
Adult |
Middle age |
Aged |
Prospective studies |
Cefotaxime |
Therapeutic use |
Cephalosporins |
Analogs and derivates |
Therapeutic use |
Cefpiramide |
Cefpiramide
![loading ... loading ...](themes/default/img/ajax-loading.gif)
vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Let. 66, št. 3, 1997, str. 123-126)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Muzlovič, Igor | 11498 |
Jereb, Matjaž, 1961- | 13300 |
Beović, Bojana | 08312 |
Tomažič, Janez, 1954- | 11347 |
Pikelj, Franjo | 13297 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.